Updates are available Correction dated 2020-06-09
Click to view Correction: https://0-doi-org.brum.beds.ac.uk/10.1186/s13195-020-00637-y
-
Authors
Ehrenberg, Alexander J.
Khatun, Ayesha
Coomans, Emma
Betts, Matthew J.
Capraro, Federica
Thijssen, Elisabeth H.
Senkevich, Konstantin
Bharucha, Tehmina
Jafarpour, Mehrsa
Young, Peter N. E.
Jagust, William
Carter, Stephen F.
Lashley, Tammaryn
Grinberg, Lea T.
Pereira, Joana B.
Mattsson-Carlgren, Niklas
Ashton, Nicholas J.
Hanrieder, Jörg
Zetterberg, Henrik
Schöll, Michael
Paterson, Ross W.
- License Information
-
More Information
Article History
Received: 8 November 2019
Accepted: 16 March 2020
First Online: 13 May 2020
Change Date: 9 June 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: AJE has accepted compensation as a consultant to Epiodyne Inc. WJJ is a consultant for Genentech, Novartis, and Bioclinica. NM serves as a consultant for the Alzheimer’s Disease Neuroimaging Initiative. LTG has received research support from AVID Radiopharmecuticals and Eli Lily. HZ has served at scientific advisory boards for Roche Diagnostics, Wave, Samumed, and CogRx; has given lectures in symposia sponsored by Alzecure and Biogen; and is a co-founder of the Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg. MS has served at a scientific advisory board for Servier. All other authors declare that they have no competing interests.
